According to a new report by Polaris Market Research, the global percutaneous coronary intervention (PCI) devices market was valued at USD 9.50 billion in 2024 and is projected to reach USD 16.47 billion by 2034, expanding at a CAGR of 5.68% over the forecast period. Growth is underpinned by the rising prevalence of cardiovascular disease, growing aging and obese populations, and favorable regulatory support across key end-use settings.

What Is Driving Percutaneous Coronary Intervention Devices Market Growth?

Demand is climbing as coronary artery disease (CAD) converges with aging and obese populations, expanding the pool of patients requiring minimally invasive cardiac intervention. Physicians and health systems are increasingly favoring PCI over more invasive alternatives, pushing device adoption across hospitals, catheterization labs, and ambulatory surgical centers. Polaris analysts note that CDC estimates of roughly 2.7 to 6.1 million Americans living with atrial fibrillation position the segment for sustained growth through 2034, with hospitals emerging as the largest revenue contributor and Asia Pacific posting the fastest incremental gains.

Key Trends Shaping the PCI Devices Industry

Robotic-Assisted PCI (R-PCI) Adoption

Robotic PCI systems, led by platforms from Corindus (Siemens Healthineers), Stereotaxis, and Robocath, are gaining traction for reducing operator radiation exposure and improving procedural precision, even as high costs continue to limit broader adoption.

AI-Guided Intervention

Artificial intelligence is improving detection of coronary blockages, guiding stent selection and placement, and shortening procedure times through real-time image-guided decision support.

Third-Generation Stent Innovation

A steady cadence of FDA approvals for third-generation drug-eluting stents is improving clinical outcomes and reducing restenosis risk, encouraging hospitals to upgrade their device inventories.

Market Segmentation: Breaking Down the PCI Devices Market

Polaris segments the PCI devices market by product and end use, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Product

The coronary stent segment accounted for the majority of revenue share in 2024, reflecting its high usage in heart-related procedures and growing patient preference for minimally invasive surgery over open procedures. Coronary catheters, guidewires, and accessories round out the product mix, supporting the broader interventional cardiology toolkit.

By End Use

Hospitals held the largest share in 2024, driven by higher patient admissions, advanced diagnostic infrastructure, and reimbursement support from Medicare and Medicaid. Catheterization labs and ambulatory surgical centers are also expanding as procedure volumes shift toward specialized, lower-cost outpatient settings.

Regional Outlook: Where Is the PCI Devices Market Growing Fastest?

North America led the market in 2024, accounting for more than 34.23% of global revenue on the back of high CAD incidence and roughly 300,000 annual balloon angioplasty procedures in the United States, while Asia Pacific is expected to post the fastest CAGR through 2034, driven by rising CAD prevalence and technological advancement in Japan, China, India, and South Korea. Within North America, the United States remains the largest single market; within Asia Pacific, Japan, India, South Korea, and China are the primary growth engines. Europe rounds out the top three, supported by an aging population and rising cardiovascular disease burden across the region.

Competitive Landscape: Leading PCI Devices Companies

Key players profiled in the report include Abbott, Boston Scientific Corporation, Medtronic PLC, Terumo Corporation, and B. Braun, who are focusing on product innovation and clinical trials for robotic-assisted delivery systems to strengthen market position across the coronary stent and hospital end-use segments outlined above. A recent move includes Abbott's May 2024 launch of its XIENCE Sierra Everolimus drug-eluting coronary stent system in India, aimed at deepening share in the fast-growing Asia Pacific region.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching the PCI devices market, this report benchmarks market share, segment-level pricing, and forecast data — by product, end use, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking robotic-assisted PCI as a growth adjacency.

More Trending Latest Reports By Polaris Market Research:

japan ophthalmic spectacle lenses and equipment market

Graphene-Enhanced Conductive Polymers Market

Virtual Data Room Market

Monoclonal Antibodies In Veterinary Health Market

AI in Drug Repurposing Market

Revenue Cycle Management Market

Carboxy Therapy Market

Sealing and Strapping Packaging Tapes Market

Fatty Acid Esters Market